These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15938991)

  • 1. Identifying patients at risk for QT interval prolongation: case studies.
    Flyer JL
    J Fam Pract; 2005 Jun; Suppl():S18-9. PubMed ID: 15938991
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing the risk for QT interval prolongation.
    Slama TG
    J Fam Pract; 2005 Jun; Suppl():S15-7. PubMed ID: 15938990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced QT prolongation.
    Michowitz MK; Michowitz Y; Zaidenstien R; Golik A
    Isr Med Assoc J; 2000 Dec; 2(12):924-8. PubMed ID: 11344777
    [No Abstract]   [Full Text] [Related]  

  • 6. Moxifloxacin: new preparation. A me-too with more cardiac risks.
    Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of history-taking in syncope patients: in whom to suspect long QT syndrome?
    Colman N; Bakker A; Linzer M; Reitsma JB; Wieling W; Wilde AA
    Europace; 2009 Jul; 11(7):937-43. PubMed ID: 19482852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
    Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
    Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine electrocardiogram and medical history in syncope: a simple approach can identify most high-risk patients.
    Cerrone M; Priori SG
    Europace; 2009 Nov; 11(11):1411-2. PubMed ID: 19706633
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency of high-risk use of QT-prolonging medications.
    Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmic potential of antimicrobial agents.
    Simkó J; Csilek A; Karászi J; Lorincz I
    Infection; 2008 Jun; 36(3):194-206. PubMed ID: 18454341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluoroquinolones and QT interval: what a physician must know].
    Savushkina OI
    Probl Tuberk Bolezn Legk; 2007; (5):8-12. PubMed ID: 17598456
    [No Abstract]   [Full Text] [Related]  

  • 16. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long QT syndrome genotyping by electrocardiography: fact, fiction, or something in between?
    Kanters JK; Graff C; Andersen MP; Hardahl T; Toft E; Christiansen M; Bloch Thomsen PE; Struijk JJ
    J Electrocardiol; 2006 Oct; 39(4 Suppl):S119-22. PubMed ID: 16920146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCA cardiotoxicity: the latest.
    Oesterheld J
    J Am Acad Child Adolesc Psychiatry; 1996 Jun; 35(6):701-2. PubMed ID: 8682748
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplifying QT prolongation for busy clinicians.
    Grindrod KA; Nagge J
    Can Fam Physician; 2019 Apr; 65(4):268-270. PubMed ID: 30979760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.